Search research articles
Contact Us
Filters
Showing results (251-260 of 348) with videos related to
Page
of 35
Sort By:
The Annals of Thoracic Surgery
|
August 1, 1991
Preliminary results of left heart bypass in pigs using a heparin-coated centrifugal pump
C Campanella, E Cameron, C Sinclair, et al.
Journal of Inorganic Biochemistry
|
January 1, 1989
Release of iron from ferritin molecules and their iron-cores by 3-hydroxypyridinone chelators in vitro
M C Brady, K S Lilley, A Treffry, et al.
Asian Pacific Journal of Tropical Biomedicine
|
September 4, 2014
Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice
Kanokwan Kulprachakarn, Nittaya Chansiw, Kanjana Pangjit, et al.
Cytometry
|
January 1, 1997
Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria
K Pattanapanyasat, S Thaithong, D E Kyle, et al.
Blood
|
February 1, 1997
Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn mice
A G Smith, B Clothier, J E Francis, et al.
Bioorganic & Medicinal Chemistry
|
April 20, 2001
Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values
Z D Liu, S Piyamongkol, D Y Liu, et al.
Toxicology Letters
|
February 15, 2011
Ga(III) complexes--the effect of metal coordination on potential systemic absorption after topical exposure
Kirsten Staff, Marc B Brown, Robert P Chilcott, et al.
European Journal of Clinical Investigation
|
November 9, 2004
Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron
C Hutchinson, W Al-Ashgar, D Y Liu, et al.
Blood
|
December 1, 1990
Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice
J B Porter, J Morgan, K P Hoyes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1993
Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients
P Lee, N Mohammed, L Marshall, et al.
Page
of 35
Search research articles
Search
Showing results (251-260 of 348) with videos related to
Sort By:
Page
of 35
The Annals of Thoracic Surgery
|
August 1, 1991
Preliminary results of left heart bypass in pigs using a heparin-coated centrifugal pump
C Campanella, E Cameron, C Sinclair, et al.
Journal of Inorganic Biochemistry
|
January 1, 1989
Release of iron from ferritin molecules and their iron-cores by 3-hydroxypyridinone chelators in vitro
M C Brady, K S Lilley, A Treffry, et al.
Asian Pacific Journal of Tropical Biomedicine
|
September 4, 2014
Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice
Kanokwan Kulprachakarn, Nittaya Chansiw, Kanjana Pangjit, et al.
Cytometry
|
January 1, 1997
Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria
K Pattanapanyasat, S Thaithong, D E Kyle, et al.
Blood
|
February 1, 1997
Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn mice
A G Smith, B Clothier, J E Francis, et al.
Bioorganic & Medicinal Chemistry
|
April 20, 2001
Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values
Z D Liu, S Piyamongkol, D Y Liu, et al.
Toxicology Letters
|
February 15, 2011
Ga(III) complexes--the effect of metal coordination on potential systemic absorption after topical exposure
Kirsten Staff, Marc B Brown, Robert P Chilcott, et al.
European Journal of Clinical Investigation
|
November 9, 2004
Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron
C Hutchinson, W Al-Ashgar, D Y Liu, et al.
Blood
|
December 1, 1990
Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice
J B Porter, J Morgan, K P Hoyes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1993
Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients
P Lee, N Mohammed, L Marshall, et al.
Page
of 35